Translate page

ASH 2011: Summaries of the CML Education Session and Key CML Presentations

Like every year in December, about 21.000 hematologists and health professionals (as well as a small group of patient advocates) convened at the Annual Meeting of the American Society of Hematology (ASH) to hear latest news from clinical trials. The CML Advocates Network has attended the CML sessions and summarized the key presentations and posters on Nilotinib, Dasatinib, Bosutinib, Ponatinib, DCC-2036, Imatinib-Interferon combination, STOP studies, as well as some studies on CML and diabetes or fatigue, complemented by a patients' perspective. Read the summary of the CML Education Session and the summary of key highlights in the scientific sessions on CML.